Clinical Trials Related to Dexamethasone

Related studies linked through entity extraction aliases.

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Status: RECRUITING
Phase: PHASE2

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Status: COMPLETED
Phase: PHASE1

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: EARLY_PHASE1

Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma

Status: TERMINATED
Phase: PHASE1

Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery

Status: COMPLETED
Phase: PHASE4

Nutrition and Pharmacological Algorithm for Oncology Patients Study

Status: TERMINATED
Phase: PHASE4

Sphenopalatine Blockade Versus Clinical Treatment

Status: UNKNOWN
Phase: NA

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury

Status: UNKNOWN
Phase: PHASE2

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Function and Composition of Regulatory B Cells in Participants With Glioblastoma

Status: TERMINATED
Phase: N/A

Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection

Status: TERMINATED
Phase: PHASE4

Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty

Status: COMPLETED
Phase: PHASE4

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma

Status: TERMINATED
Phase: PHASE2

A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Status: TERMINATED
Phase: PHASE1